Status:
UNKNOWN
Study of Prevalence of the Covid-19 Among the Staff of the Emergency Department
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
Since December 2019, a new coronavirus, SARS-CoV-2, has been identified in the city of Wuhan in Hubei province in China and is the cause of a global pandemic. This highly contagious virus is responsib...
Detailed Description
The aim of the study is to study the seroprevalence of SARS-CoV2 among healthcare personnel in the emergency services of the Strasbourg University Hospitals and the Besançon University Hospital.
Eligibility Criteria
Inclusion
- Adult (≥18 years old)
- Part of the emergency staff of the HUS or Besançon University Hospital having worked during the period of the covid-19 pandemic, from March 1, 2020 to May 31, 2020.
- Having carried out serology within the framework of the recommendations of the High Authority of Health of May 2, 2020 on the screening of caregivers
- Having given consent for its biological resources to be reused for research purposes
Exclusion
- Subject having expressed opposition to participating in the study
Key Trial Info
Start Date :
January 10 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2024
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT06200610
Start Date
January 10 2021
End Date
January 1 2024
Last Update
January 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service d'Accueil des Urgences - CHU de Strasbourg - France
Strasbourg, France, 67091